3 Results for "

externa

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "externa" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13451
CAS No.: 209342-40-5
Purity:  98.75%
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Finafloxacin is an orally active fourth-generation fluoroquinolone broad-spectrum antibiotic. Finafloxacin exhibits stronger antibacterial activity in acidic pH environments and is not easily affected by bacterial multidrug efflux transporters. Finafloxacin is effective against a variety of extracellular pathogenic bacteria, and can also accumulate in macrophages, showing excellent antibacterial activity against intracellular Staphylococcus aureus, Listeria monocytogenes, Legionella pneumophila, Burkholderia pseudomallei, and other pathogens. Finafloxacin has been approved by the U.S. FDA for research on acute otitis externa mediated by Pseudomonas aeruginosa. Finafloxacin is also used in studies related to diseases such as melioidosis, inhalational tularemia, and inhalational plague .
loading...
    loading...
Cat. No.: HY-B1051R
CAS No.: 2135-17-3
Synonyms: Flumetasone (Standard)
Research Areas:  

Inflammation/Immunology

Flumethasone (Standard) is the analytical standard of Flumethasone. This product is intended for research and analytical applications. Flumethasone is a corticosteroid, a topical agent used in combination with Clioquinol for the study of otitis externa and otomycosis. When used in animal models, Flumethasone's anti-inflammatory activity is 420 times higher than that of Cortisone.
loading...
    loading...
Cat. No.: HY-13451R
CAS No.: 209342-40-5
Research Areas:  

Infection

Finafloxacin (Standard) is the analytical standard of Finafloxacin (HY-13451). This product is intended for research and analytical applications. Finafloxacin is an orally active fourth-generation fluoroquinolone broad-spectrum antibiotic. Finafloxacin exhibits stronger antibacterial activity in acidic pH environments and is not easily affected by bacterial multidrug efflux transporters. Finafloxacin is effective against a variety of extracellular pathogenic bacteria, and can also accumulate in macrophages, showing excellent antibacterial activity against intracellular Staphylococcus aureus, Listeria monocytogenes, Legionella pneumophila, Burkholderia pseudomallei, and other pathogens. Finafloxacin has been approved by the U.S. FDA for research on acute otitis externa mediated by Pseudomonas aeruginosa. Finafloxacin is also used in studies related to diseases such as melioidosis, inhalational tularemia, and inhalational plague .
loading...
    loading...